Staying on top of regulatory changes, new technical innovations, and industry-disrupting competitors has never been harder. With so much information available, how do you ensure you have the insight you need to drive your business forward and seize opportunities before the competition?
Our regulatory and scientific experts are here to help you stay up to speed with new trends and research. Let them share their expertise and insight so you can focus on building your business.
Explore the benefits of CBGA testing for regulatory compliance, product safety, and innovation. Broughton delivers precision analytics for cannabis brands.
Click to download
Bringing medicinal cannabis products to market can be complex, but your testing doesn’t have to be. Broughton offers a full suite of in-house testing services, including in-process testing, GMP-certified import testing, QC batch release, and ICH-compliant stability studies.
Click to download
Ensure product quality, safety & compliance with Broughton’s ICH-compliant cannabis stability testing. Get precise shelf-life data & real-time monitoring
Click to download
Broughton’s GMP QC Batch Release Testing ensures medicinal cannabis products comply with UK regulations, verifying safety, potency, and label accuracy. Our GMP-certified laboratory streamlines batch approval, reducing delays and ensuring a consistent supply of high-quality, compliant products to the market.
Click to download
Ensure regulatory compliance with Broughton's GMP-Certified Imports Testing for medicinal cannabis. Verify quality, safety & label accuracy for UK market entry.
Click to download
Introducing Broughton’s In-Process Testing Service: a streamlined solution for medicinal cannabis cultivators seeking rapid and efficient cannabinoid content analysis
Click to download
As the beneficial effects of medicinal cannabis gain greater acceptance and more consumers begin to use cannabis-derived products, there is an ever-increasing need for cultivators to ensure that their products are tested to the required standards to ensure both product safety and quality.
Click to download
Broughton is a leading global contract research organisation specialising in tobacco harm reduction, medicinal cannabis, cannabinoids, and pharmaceuticals, we can help bring category innovators life-enhancing products to market.
Click to download
As the medical cannabis market grows, expertise in testing, regulatory compliance, and quality control play a pivotal role in assisting category innovators in bringing their products to market.
Click to download
With over 60,000 liters of in-house ICH stability storage capacity, supported by a team of highly qualified scientists and GMP-accredited laboratory testing facilities, we have approximately 250 live studies in progress and offer a full range of stability services to help bring your product to market or ensure its ongoing compliance requirements.
Click to download
Enhancing the positive reputation of cannabis by accelerating safe, efficacious, and high-quality cannabis products to a regulated market. Learn more about our cannabis services.
Click to download
This guide examines the key steps in the cannabis analytical testing process and what cultivators need to consider when selecting a testing partner.
Click to download
The evaluation of extractables and leachables (E&L) is an essential component of the pharmaceutical development process.
Click to download
Our team of in-house toxicologists reviews and evaluates toxicological data on a wide range of chemicals to produce independent expert opinions on risk assessment. We then advise on the strategies to mitigate or reduce those risks to protect corporate reputation and public health.
Click to download
Learn more about our UK and EU Novel Food Application scientific consultancy and analytical testing support.
Click to download
Our product development and regulatory experts can help you meet expectations at key milestones in your product development project to better inform decision making and investment choices.
Click to download
The rapid growth of the cannabis market has outpaced the establishment of comprehensive safety standards and regulations. To help create a pathway towards safe, secure, and reliably-regulated CBD products, Cristelle Santos, Consultant Toxicologist at Broughton, has proposed a safety framework.
Click to download
We believe that the sectors we work within expect a continually improving service where we constantly strive to improve processes and Quality.
Click to download
ToxHQ by Broughton offers automated, data-driven risk assessments and delivers fast, high-quality toxicological evaluations, so you can launch safer products with confidence.
Click to download
In this whitepaper, we discuss the stability studies that may be performed during pharmaceutical development and in support of a regulatory dossier to support the licensing of a medicinal drug product.
Click to download
In this whitepaper, we discuss the range of validated analytical methods required to support the comprehensive characterization of various dosage forms of cannabinoid products.
Click to download
Both the FDA and EFSA have raised several concerns about CBD as supplements and as an ingredient in food and drinks, citing potential liver damage as a possible side effect. Is CBD really that toxic to the liver? To find out, toxicologist Cristelle Santos looks at the scientific evidence.
Click to download
Broughton summarises the regulatory pathways available for cannabinoid products in the UK market and the legal requirements for each potential market route.
Click to download
To develop cannabis products that can both enhance the quality of life of cannabis users and comply with current and future regulations, we believe that fi rst we need to understand what cannabis is, how people use it, and how it affects the human body and mind. This white paper aims to provide essential but concise information about these areas, supported by scientific evidence.
Click to download
In this whitepaper, Broughton discusses the susceptibility of cannabinoids to degrade and summarizes the main degradation pathways of the primary cannabinoid products on the market; tetrahydrocannabinol (THC) and Cannabidiol (CBD).
Click to downloadThe 2025 Food and Drug Law Institute (FDLI) Tobacco and Nicotine Conference delivered something the industry has been waiting for: a visible and ....
When FDA deployed the “fatal flaw” concept during ENDS PMTA reviews, it was seen by many as a subjective screen built on guidance rather than ....
The 2025 CORESTA Product Science and Product Technology (PSPT) Conference brought together researchers and industry experts to discuss the latest ....
Arrange a meeting with a scientific or regulatory expert to discuss your project and learn how we can help accelerate your product to market to maximize your success.
